Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women

NCT00877097 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

167

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Klodronate and Kliogest
PROCEDURE: Placebo+ Kliogest
DRUG: Bonefos

Sponsor

Kuopio University Hospital